Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapy.

  • Authors : Kim HM; Genuv Inc., B1 Shinyoung Building, 14 Gyeonghuigung-gil, Jongno-gu, Seoul, Republic of Korea.; Kim KJ

Subjects: Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/immunology ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/metabolism ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/antagonists & inhibitors

  • Source: BMC immunology [BMC Immunol] 2024 May 11; Vol. 25 (1), pp. 29. Date of Electronic Publication: 2024 May 11.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

Record details

×
Academic Journal

Identification of key genes and the pathophysiology associated with allergen-specific immunotherapy for allergic rhinitis.

  • Authors : Fan K; Department of Otorhinolaryngology-Head and Neck Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.; Department of Allergy, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.

Subjects: Rhinitis, Allergic*/Rhinitis, Allergic*/Rhinitis, Allergic*/genetics ; Rhinitis, Allergic*/Rhinitis, Allergic*/Rhinitis, Allergic*/therapy ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics

  • Source: BMC immunology [BMC Immunol] 2023 Jul 10; Vol. 24 (1), pp. 19. Date of Electronic Publication: 2023 Jul 10.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

Record details

×
Academic Journal

Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing.

  • Authors : Lee YY; Division of Pediatric Neurosurgery, Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Subjects: Cytokine-Induced Killer Cells* ; Neoplasms*; Humans

  • Source: BMC immunology [BMC Immunol] 2023 Jun 29; Vol. 24 (1), pp. 14. Date of Electronic Publication: 2023 Jun 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

Record details

×
Academic Journal

The immune subtypes and landscape of sarcomas.

  • Authors : Weng W; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.

Subjects: Immune Checkpoint Inhibitors* ; Sarcoma*/Sarcoma*/Sarcoma*/drug therapy ; Sarcoma*/Sarcoma*/Sarcoma*/therapy

  • Source: BMC immunology [BMC Immunol] 2022 Sep 24; Vol. 23 (1), pp. 46. Date of Electronic Publication: 2022 Sep 24.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

Record details

×
Academic Journal

Oncolytic herpes simplex virus and immunotherapy.

  • Authors : Ma W; Ruminant Diseases Research Center, Shandong Provincial Key Laboratory of Animal Resistance Biology, College of Life Sciences, Shandong Normal University, Jinan, 250014, China.; He H

Subjects: Immunotherapy* ; Oncolytic Virotherapy*; Neoplasms/Neoplasms/Neoplasms/*therapy

  • Source: BMC immunology [BMC Immunol] 2018 Dec 18; Vol. 19 (1), pp. 40. Date of Electronic Publication: 2018 Dec 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

Record details

×
Academic Journal

Macrophage-targeted anti-CCL2 immunotherapy enhances tumor sensitivity to 5-fluorouracil in a Balb/c-CT26 murine colon carcinoma model measured using diffuse reflectance spectroscopy.

  • Authors : Bess SN; Department of Biomedical Engineering, University of Arkansas, 1 University of Arkansas, Fayetteville, AR, 72701, USA.; Greening GJ

Subjects: Carcinoma*/Carcinoma*/Carcinoma*/drug therapy ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/drug therapy; Animals

  • Source: BMC immunology [BMC Immunol] 2022 Apr 23; Vol. 23 (1), pp. 20. Date of Electronic Publication: 2022 Apr 23.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

Record details

×
Academic Journal

Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants.

Subjects: Immunotherapy, Active*; Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*immunology

  • Source: BMC immunology [BMC Immunol] 2017 Jul 26; Vol. 18 (1), pp. 39. Date of Electronic Publication: 2017 Jul 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

Record details

×
Academic Journal

An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies.

  • Authors : Chen L; Department of Research and Development, Shenzhen Institute for Innovation and Translational Medicine, Shenzhen International Biological Valley-Life Science Industrial Park, Dapeng New District, Shenzhen, China.; Dong L

Subjects: Immunotherapy, Adoptive/Immunotherapy, Adoptive/Immunotherapy, Adoptive/*methods ; Neoplasms/Neoplasms/Neoplasms/*immunology ; Neoplasms/Neoplasms/Neoplasms/*therapy

  • Source: BMC immunology [BMC Immunol] 2021 Sep 28; Vol. 22 (1), pp. 65. Date of Electronic Publication: 2021 Sep 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

Record details

×
Academic Journal

Targeted immune epitope prediction to HHLA2 and MAGEB5 protein variants as therapeutic approach to related viral diseases.

  • Authors : Achinko DA; PepVax, Inc., 0411 Motor City Drive, Suite #750, Bethesda, MD, 20817, USA. .; Dormer A

Subjects: Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*metabolism ; Epitopes, T-Lymphocyte/Epitopes, T-Lymphocyte/Epitopes, T-Lymphocyte/*immunology ; Immunoglobulins/Immunoglobulins/Immunoglobulins/*immunology

  • Source: BMC immunology [BMC Immunol] 2021 Jul 28; Vol. 22 (1), pp. 49. Date of Electronic Publication: 2021 Jul 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

Record details

×
  • 1-10 of  209 results for ""Immunotherapy""